(CNH, ALEX, PCH, PWRM) StockUpdate From PennyOmega.com

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins.

Power3 Medical Products, Inc. (OTC.BB:PWRM) is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.

Power3 Medical's business focus is the development of commercial applications for their proprietary technologies. The scientific team is on the leading edge of the proteomics industry through their discovery of protein footprints, pathways, and mechanisms of disease. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer, neurodegenerative disease and drug resistance in cancer. The Company is in a strong competitive position with over 190 identified biomarkers and a state-of-the-art proteomics laboratory.

BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a stand alone diagnosis nor a guarantee.

This test was developed and its performance characteristics determined by the Power3 Medical Products Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research. This laboratory is certified under the Clinical Laboratory Improvement Amendment of 1988 (“CLIA”) as qualified to perform high complexity clinical testing.

******************************************

Potlatch Corporation (NYSE:PCH) announced that its Board of Directors has voted to transfer its stock exchange listing from The New York Stock Exchange to The NASDAQ Global Select Market, an exchange of The NASDAQ OMX Group Inc. (NASDAQ:NDAQ). The Company currently expects that its common stock will commence trading on the NASDAQ on December 17, 2010 and will continue to be listed under the ticker symbol “PCH.” “Our switch to NASDAQ is part of our continued focus on delivering shareholder value,” said Eric Cremers, vice president finance and chief financial officer of Potlatch. “We believe NASDAQ OMX’s global technology leadership and vast product offerings provide Potlatch and our shareholders with increased value.”

Potlatch is a Real Estate Investment Trust (REIT) with approximately 1.5 million acres of timberland in Arkansas, Idaho, and Minnesota. Potlatch, a verified forest practices leader, is committed to providing superior returns to stockholders through long-term stewardship of its forest resources.

******************************************

Alexander & Baldwin, Inc. (NYSE:ALEX) announced that it has acquired Rancho Temecula Town Center for $48 million. The 165,500 square-foot, 11-building neighborhood shopping center is located in Temecula, California, in the southwest region of Riverside County. “The acquisition of Rancho Temecula Town Center extends our real estate strategy of investing in quality properties located in areas having above-average growth prospects and favorable demographics,” said A&B Properties President Norbert M. Buelsing. “Temecula is expected to see continued population growth as an attractive alternative to neighboring Los Angeles, Orange and San Diego Counties. The property is well-anchored by Henry’s Market, LA Fitness, Rite-Aid and BevMo!, complemented by a diverse group of restaurants and service providers, and is presently 97 percent occupied. The center was constructed in 2007 and is one of Temucula’s best performing retail centers.”

Alexander & Baldwin is headquartered in Honolulu, Hawaii and is engaged in ocean transportation and logistics services through its subsidiaries, Matson Navigation Company, Inc., Matson Integrated Logistics, Inc. and Matson Global Distribution Services; in real estate through A&B Properties, Inc.; and in agribusiness through Hawaiian Commercial & Sugar Company and Kauai Coffee Company, Inc.

******************************************

CNH Global NV (NYSE:CNH) has won two SIMA Innovation Awards ahead of the show’s opening in February 2011. A Gold medal has been received for a new automatic vehicle-to-vehicle synchronisation solution, which expands Case IH Advanced Farming Systems (AFS) portfolio. A Silver medal has been awarded for a new CVT PTO concept, which increases tractor productivity and efficiency.

CNH Global N.V. engages in engineering, manufacturing, marketing, and distributing agricultural and construction equipment worldwide. The company operates through three segments: Agricultural Equipment, Construction Equipment, and Financial Services.

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).